Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selay Lam

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
International Journal of Laboratory Hematology|December 5, 2018
Gaucher disease screening at a general adult hematology tertiary care centre: A prospective studySteven A Russell, Michelle Sholzberg, Joy Mangel, et al.
British Journal of Haematology|July 21, 2022
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphomaPaolo Strati, Morton Coleman, Rebecca Champion, et al.
JCO Oncology Practice|June 3, 2025
Patient-Centered Genomic Diagnostic Testing for AML: A Quality Improvement ProjectJenny M Ho, Uday Deotare, Aatif Qureshi, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 9, 2024
Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort StudyAlexandra Hillyer, Anthony Quint, Artin Ghassemian, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2021
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic LeukemiaMatthew C Cheung, Nicole Mittmann, Carolyn Owen, et al.
Blood|May 12, 2026
Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival AnalysisEfstathios Kastritis, Giovanni Palladini, Monique C Minnema, et al.
The New England Journal of Medicine|June 30, 2021
Daratumumab-Based Treatment for Immunoglobulin Light-Chain AmyloidosisEfstathios Kastritis, Giovanni Palladini, Monique C Minnema, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Laboratory Hematology|December 5, 2018
Gaucher disease screening at a general adult hematology tertiary care centre: A prospective studySteven A Russell, Michelle Sholzberg, Joy Mangel, et al.
British Journal of Haematology|July 21, 2022
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphomaPaolo Strati, Morton Coleman, Rebecca Champion, et al.
JCO Oncology Practice|June 3, 2025
Patient-Centered Genomic Diagnostic Testing for AML: A Quality Improvement ProjectJenny M Ho, Uday Deotare, Aatif Qureshi, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 9, 2024
Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort StudyAlexandra Hillyer, Anthony Quint, Artin Ghassemian, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2021
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic LeukemiaMatthew C Cheung, Nicole Mittmann, Carolyn Owen, et al.
Blood|May 12, 2026
Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival AnalysisEfstathios Kastritis, Giovanni Palladini, Monique C Minnema, et al.
The New England Journal of Medicine|June 30, 2021
Daratumumab-Based Treatment for Immunoglobulin Light-Chain AmyloidosisEfstathios Kastritis, Giovanni Palladini, Monique C Minnema, et al.
Pageof 2